Kleinschnitz, Christoph,Nolte, Marc,Siren, Anna-Leena,Albert-Weissenberger, Christiane,Hopp-Kraemer, Sarah
申请号：
AU2015276089
公开号：
AU2015276089A1
申请日:
2015.06.18
申请国别(地区):
AU
年份:
2017
代理人:
摘要：
The present invention relates to the use of a direct Factor XII (FXII) inhibitor in the treatment of a neurotraumatic disorder resulting from a traumatic injury of the brain (traumatic brain injury, TBI) or the spinal cord (spinal cord injury, SCI).
